A biology teacher has become the first patient in the UK to receive a “gamechanger” therapy to treat multiple sclerosis (MS).
The CAR T-cell treatment, which experts believe could “transform” lives by halting or slowing down progression of the disease, is custom-built for each patient in the lab.
